Pages that link to "Q88792521"
Jump to navigation
Jump to search
The following pages link to Max Nieuwdorp (Q88792521):
Displaying 50 items.
- Duodenal infusion of donor feces for recurrent Clostridium difficile (Q28283517) (← links)
- Therapeutic potential of fecal microbiota transplantation (Q28298108) (← links)
- The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial (Q28540034) (← links)
- Probiotics, prebiotics, and the host microbiome: the science of translation (Q28657826) (← links)
- Causality of small and large intestinal microbiota in weight regulation and insulin resistance (Q28828501) (← links)
- Durable coexistence of donor and recipient strains after fecal microbiota transplantation. (Q31087089) (← links)
- SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus (Q33560966) (← links)
- A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx (Q33614637) (← links)
- Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice (Q33775709) (← links)
- Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans (Q33794679) (← links)
- Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. (Q33914924) (← links)
- Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study (Q33986714) (← links)
- Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume (Q34776309) (← links)
- The gut microbiome as novel cardio-metabolic target: the time has come! (Q35038619) (← links)
- Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome (Q35043680) (← links)
- Fecal microbiota transplantation: facts and controversies (Q35044957) (← links)
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. (Q35062300) (← links)
- Role of the microbiome in energy regulation and metabolism (Q35100445) (← links)
- Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans (Q35120945) (← links)
- The gut microbiota in sickness and health (Q35159506) (← links)
- Microbial modulation of insulin sensitivity (Q35235971) (← links)
- Insights into the role of the microbiome in obesity and type 2 diabetes (Q35533602) (← links)
- Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus (Q35617250) (← links)
- About the gut microbiome as a pharmacological target in atherosclerosis (Q35670026) (← links)
- Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia. (Q35936964) (← links)
- Hypercoagulability in the metabolic syndrome. (Q36076184) (← links)
- Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study (Q36204111) (← links)
- Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration (Q36223678) (← links)
- The endothelial glycocalyx: a potential barrier between health and vascular disease (Q36251700) (← links)
- Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans (Q36320040) (← links)
- Glycocalyx and endothelial (dys) function: from mice to men. (Q36749166) (← links)
- Metabolic modulation of inflammation-induced activation of coagulation (Q37130323) (← links)
- Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease (Q37357798) (← links)
- Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. (Q37456235) (← links)
- The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis (Q37583530) (← links)
- The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight (Q37584881) (← links)
- Probiotics and prebiotics: prospects for public health and nutritional recommendations (Q38191264) (← links)
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans (Q38389141) (← links)
- Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study (Q38582703) (← links)
- Gut Microbiota and Energy Expenditure in Health and Obesity. (Q38602319) (← links)
- Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion. (Q38602340) (← links)
- GUT MICROBIOTA AND THE GUT-BRAIN AXIS: NEW INSIGHTS IN THE PATHOPHYSIOLOGY OF METABOLIC SYNDROME. (Q38677270) (← links)
- European consensus conference on faecal microbiota transplantation in clinical practice. (Q38770514) (← links)
- SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome. (Q38932322) (← links)
- Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk (Q38965789) (← links)
- An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases. (Q40446130) (← links)
- Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans (Q40796420) (← links)
- Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy. (Q47126403) (← links)
- Effect of Single Dose of RANKL Antibody Treatment on Acute Charcot Neuro-osteoarthropathy of the Foot (Q48354314) (← links)
- Does disease start in the mouth, the gut or both? (Q64074746) (← links)